Meloxicam and Folate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meloxicam (meloxicam) and Folate (folic acid). Common drug interactions include loss of consciousness among females and spinal osteoarthritis among males.
The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Folate. It is created by eHealthMe based on reports of 66 people who take the same drugs from the FDA, and is updated regularly.
What is Meloxicam?
Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,016 Meloxicam users. Check the latest studies of Meloxicam.
What is Folate?
Folate has active ingredients of folic acid. It is often used in rheumatoid arthritis. eHealthMe is studying from 6,546 Folate users. Check the latest studies of Folate.
66 people who take Meloxicam and Folate together, and have interactions are studied.

What are the common drug interactions of Meloxicam and Folate, by gender? *:
female:
- Loss of consciousness
- Abdominal pain
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Amylase increased
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
- Anorectal disorder
- Atypical femur fracture
- Back pain
- Blood albumin decreased
male:
- Spinal osteoarthritis (joint cartilage loss in spine)
- Therapeutic response decreased (less preventive response)
- Rash
- Abasia (inability to walk)
- Fall
- Mobility decreased (ability to move is reduced)
- Arthropathy
- Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
- Ankle fracture
- Bone density decreased
What are the common drug interactions of Meloxicam and Folate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
- Inflammation
- Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
- Uterine polyp (a mass in the inner lining of the uterus)
40-49:
- Spinal osteoarthritis (joint cartilage loss in spine)
- Therapeutic response decreased (less preventive response)
- Tooth disorder (tooth disease)
- Arthralgia (joint pain)
- Abdominal pain upper
- Disease progression
- Drug ineffective
- Fatigue (feeling of tiredness)
- Hepatic enzyme increased
- Hypertension (high blood pressure)
50-59:
- Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance)
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Injection site inflammation
- Injection site injury
- Injection site pain
- Injection site pustule (injection site pimple)
- Injection site reaction
- Angina pectoris (chest pain due to ischemia of the heart muscle)
- Anxiety
- Arthralgia (joint pain)
60+:
- Eye inflammation
- Hypoaesthesia (reduced sense of touch or sensation)
- Bone density decreased
- Disease recurrence
- Herpes simplex (herpes simplex is a common viral infection)
- Hypertension (high blood pressure)
- Malaise (a feeling of general discomfort or uneasiness)
- Osteoporosis (bones weak and more likely to break)
- Stomatitis (inflammation of mucous membrane of mouth)
- Tooth loss
What are the existing conditions these people have? *
- Neuropathy Peripheral (surface nerve damage): 11 people, 16.67%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 15.15%
- High Blood Cholesterol: 9 people, 13.64%
- Pain: 9 people, 13.64%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 13.64%
- Hypersensitivity: 6 people, 9.09%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 9.09%
- Sleep Disorder: 6 people, 9.09%
- Constipation: 5 people, 7.58%
- Fibromyalgia (a long-term condition which causes pain all over the body): 5 people, 7.58%
* Approximation only. Some reports may have incomplete information.
Do you take Meloxicam and Folate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Meloxicam and Folate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meloxicam:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Folate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meloxicam and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Folate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
- Lai SW, Lin CL, Liao KF, "Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case–Control Study", Clinical drug investigation, 2015 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on meloxicam and folic acid (the active ingredients of Meloxicam and Folate, respectively), and Meloxicam and Folate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Hc cause Speech Impairment (Adult)? - a second ago
- Drug interactions of Aromasin and Fluticasone Propionate - 5 seconds ago
- Could Innohep cause Haematocrit Decreased? - 6 seconds ago
- Drug interactions of Carbidopa And Levodopa and Cyclobenzaprine Hydrochloride - 10 seconds ago
- Drug interactions of Zofran and Mometasone Furoate - 45 seconds ago
- Drug interactions of Ginger and Duloxetine Hydrochloride - 49 seconds ago
- Humulin R vs. Glimepiride, side effect and effectiveness comparison - 52 seconds ago
- Drug interactions of Naloxone and Metolazone - 53 seconds ago
- Ambien Cr vs. Caffeine, side effect and effectiveness comparison - 54 seconds ago
- Could Gemcitabine cause Hepatic Lesion? - a minute ago